Das Journal of Medical Drug Reviews ist ein "Open Access"-Journal. Alle Artikel können für die persönliche Information des einzelnen Nutzers kostenlos heruntergeladen werden. Hingegen ist für eine kommerzielle Nutzung der Inhalte dieses Journals in jedwedem Medium die schriftliche Genehmigung des Verlages zwingend erforderlich. Das Urheberrecht liegt ausschließlich beim Verlag Reprint Publications GmbH & Co. KG.


© Reprint Publications 2016,
Webdesign Bothgrafik,
Programmierung amr

 
 
J Med Drug Rev 2012;2;13-18

Apixaban sets benchmarks for thromboprophylaxis in cases of hip and knee replacement

ABSTRACT (Review-Artikel in deutscher Sprache) Major orthopedic surgical procedures such as knee or hip replacement surgeries are associated with a high risk of deep venous thrombosis (DVT) and related complications. Therefore,...[mehr]

Kategorie: Jahrgang 2012

J Med Drug Rev 2012;2;5-12

Rifaximin and Polyethylene Glycol as treatment modalities in hepatic encephalopathy

ABSTRACT (Review in English and German language) Treatment of hepatic encephalopathy (HE) is still a challenge as the efficacy of the former gold-standard lactulose has been questioned. In addition to disturbed ammonia...[mehr]

Kategorie: Jahrgang 2012

J Med Drug Rev 2011;1;45-52

Belatacept A new immunosuppressant after kidney transplantation acts via selective T-cell costimulation inhibition.

ABSTRACT (Review-Artikel in deutscher Sprache) Belatacept is a new treatment option for the prevention of acute organ rejection in patients after kidney transplantation. Its mode of action totally differs from all known...[mehr]

Kategorie: Jahrgang 2011

J Med Drug Rev 2011;1;29-36

Fingolimod The oral alternative to interferon beta, highly efficient and safe in multiple sclerosis

ABSTRACT (Review-Artikel in deutscher Sprache) Fingolimod is a new significant option for oral treatment of multiple sclerosis. Its mode of action totally differs from all known standard therapies. Fingolimod binds to the...[mehr]

Kategorie: Jahrgang 2011

J Med Drug Rev 2011;1;21-28

Indacaterol in COPD: the first ultra-long-acting ß2-agonist

ABSTRACT (Review-Artikel in deutscher Sprache) The standard maintenance therapy of chronic obstructive pulmonary disease (COPD) comprises the anticholinergic tiotropium as well as long-acting ß2-agonists like salmeterol and...[mehr]

Kategorie: Jahrgang 2011

J Med Drug Rev 2011;1;13-20

Dabigatran for prevention of ischemic stroke in atrial fibrillation: Is the era of vitamin K antagonists coming to an end?

ABSTRACT (Review-Artikel in deutscher Sprache) Patients with atrial fibrillation have a high risk for ischemic stroke and systemic embolism and usually receive vitamin K antagonists for antithrombotic therapy. However, effective...[mehr]

Kategorie: Jahrgang 2011

J Med Drug Rev 2011;1;5-12

Rifaximin: high local antibiotic efficacy in the gastrointestinal tract with minimal systemic bioavailability

ABSTRACT (Review-Artikel in deutscher Sprache) Basics: Rifaximin is an antibiotic exerting local activity in the gastrointestinal tract with a broad efficacy spectrum und minimal systemic bioavailability. Rifaximin differs from...[mehr]

Kategorie: Jahrgang 2011

Treffer 31 bis 37 von 37
<< Erste < Vorherige 1-10 11-20 21-30 31-37 Nächste > Letzte >>